Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.548
-0.006 (-0.39%)
At close: Jan 30, 2026
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €145.05 million as of January 30, 2026. Its market cap has decreased by -0.77% in one year.
Market Cap
145.05M
Enterprise Value
112.05M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.55
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 145.05M, an increase of 18,211.46%. That is a compound annual growth rate of 31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 145.05M | -1.78% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 281.34M |
| Transgene | 251.37M |
| Cellectis | 236.14M |
| ABIONYX Pharma | 135.11M |
| MaaT Pharma | 123.69M |
| Adocia | 117.95M |
| Sensorion | 112.63M |
| OSE Immunotherapeutics | 108.02M |